In The News
InCyte Pathology’s Medical Director Receives College of American Pathologists Certificates of Recognition
Spokane, Wash., 06 December 2011 — InCyte Pathology’s Laboratory Medical Director, David C. Hoak, M.D., recently received the College of American Pathologists (CAP) Laboratory Medical Director Advanced Practical Pathology Program, as well as the Breast Predictive Factors Testing (BPFT)Advanced Practical Pathology Program Certificate of Recognition.
InCyte Pathology Announces the Expansion of Its Oncology Diagnostic Services
Spokane, Wash., 7 September 2011 — InCyte Pathology welcomes hematopathologist, Ayumi I. Corn, M.D., to its growing cancer diagnostic division. InCyte Pathology’s hematopathologists work closely with area oncologists to decide the best treatment for patients with diseases of the blood, bone marrow and lymph nodes.
InCyte Pathology Purchases Davis-Sameh-Meeker Laboratories
Spokane, Wash., 22 Mar 2011 — InCyte Pathology, PS announced today that it has entered into an agreement to purchase Davis-Sameh-Meeker Laboratories (DSM) in Walla Walla, Washington. The expected closing date for the sale is April 1, 2011. DSM Laboratories has provided clinical and anatomic pathology services in the Walla Walla community for 63 years.
InCyte Pathology Medical Director Elected President of The American Pathology Foundation
Spokane, Wash., 6 Oct 2010 — The American Pathology Foundation (APF) recently elected David C. Hoak, M.D. as its 41st President. This is a two year appointment, which commenced earlier this month. APF is a non-profit professional society, which provides quality educational programs and practice management resources for its members including pathology practice managers/administrators and pathologists in private practice, hospital and academic settings, independent labs and residency.
InCyte Pathology Increases Lab Efficiencies With New Staining Instruments
Spokane, Wash., 6 July 2010 — InCyte Pathology has completed implementation of the BenchMark ULTRA from Ventana Medical Systems, Inc. to its suite of staining instruments. The BenchMark ULTRA is a fully automated, random and continuous access slide staining system that processes IHC (immunohistochemistry) and ISH (in situ hybridization) tests simultaneously, with stat capabilities for rapid patient diagnosis.
Press Release: Benchmark ULTRA
InCyte Pathologist Making A Difference In Region’s Dental Health
Spokane, Wash., 21 May 2010 — InCyte Pathologist, Robert Achterberg, DDS, MS, has been making a difference in the Spokane community since he and his wife, Nancy, moved here in 2003. When Dr. Achterberg isn’t signing out cases at InCyte Pathology, he is actively working on bettering Spokane’s dental health for those citizens who can least afford it.
Press Release: Dr. Robert Achterberg
InCyte Pathologist Wins 2010 Spirit of Planetree Physician Champion Award
Spokane, Wash., 18 May 2010 – Kadlec Regional Medical Center announced that Brian Staley, M.D. is the winner of this year’s Spirit of Planetree Physician Champion Award, which recognizes a physician who champions the Planetree model of patient-centered care and whose actions demonstrate her or him to be a role model for other medical staff members.
Press Release: Planetree Award
InCyte Pathology Adds Advanced High-Risk HPV Screening
Spokane, Wash., 8 May 2010 – InCyte Pathology is offering a new test for women to screen for the presence of high-risk human papillomavirus (HPV) types, which are strongly associated with the development of cervical cancer.
Press Release: High-Risk HPV Screening
Journal of Business – May 6, 2010 – Healthcare Report
Longtime Spokane Valley pathology lab adds equipment and taps broader market to boost its volume. Read the article in its entirety:
Journal of Business article: May 6, 2010
New Test Procedure Enhances Routine Cervical Cancer Screening for Chlamydia trachomatis and Neisseria gonorrhoeae
Spokane, Wash., 12 April 2010 — InCyte Pathology announced early this month that it began providing enhanced pap smear testing using amplified DNA assays that additionally screen for Chlamydia trachomatis and Neisseria gonorrhoeae.
